Natsuko Okita, M.D., Ph.D.

Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Japan

Poster(s):

• (P 35) GENOMIC ALTERATIONS IN ADVANCED GASTROINTESTINAL STROMAL TUMORS AS REVEALED BY COMPREHENSIVE GENOMIC PROFILING TESTS

• (P 547) A PHASE II TRIAL OF TAZEMETOSTAT FOR PATIENTS WITH UNRESECTABLE OR METASTATIC EPITHELIOID SARCOMA (TAZETTA TRIAL)